The International IVF Initiative - i3

CRISPR Genome Editing. How, What and Why?

HELEN O'NEILL

CRISPR Genome Editing.  How, What and Why?
CRISPR Genome Editing.  How, What and Why?
CRISPR Genome Editing.  How, What and Why?
Load image into Gallery viewer, CRISPR Genome Editing.  How, What and Why?
Load image into Gallery viewer, CRISPR Genome Editing.  How, What and Why?
Load image into Gallery viewer, CRISPR Genome Editing.  How, What and Why?

CRISPR Genome Editing. How, What and Why?

 

DR. HELEN O'NEILL

Dr. Helen O’Neill is a lecturer in Reproductive and Molecular Genetics and Director for the MSc in Reproductive Science and Women’s Health at the Institute for Women’s Health, University College London (UCL). Her research focusses on preimplantation embryo development and the use of genome editing to assess understanding and treatment of disorders of infertility. Dr. O’Neill has an honours degree in Genetics, an MSc in Prenatal Genetics and Fetal Medicine from UCL and did her PhD and postdoctoral research on the genetics of ovarian development in the Department of Stem cell biology and developmental genetics at the National Institute for Medical Research. She lectures both masters and medical students and is active in public engagement involving genome editing. Dr. O’Neill is CEO and Founder of Hertility Health, a precision medicine based approach to reproductive health



Reviews

Open tab

Customer Reviews

Based on 1 review Write a review
Close (esc)

Membership

Members get free stuff and can stay up to date with the latest sessions from I3.

Become a Member

Age verification

By clicking enter you are verifying that you are old enough to consume alcohol.

Search

Shopping Cart

Your cart is currently empty.
Shop now